Exercise of Options, Issue of Equity and TVR

Summary by AI ^BETAClose X

Brave Bison Group PLC announced that employees exercised options for 202,451 ordinary shares, leading to an application for their admission to trading on AIM on December 18, 2025. Following this, the Company's total issued ordinary shares will be 102,474,298, with no shares held in treasury, a figure shareholders can use for disclosure calculations.

Disclaimer*

Brave Bison Group PLC

12 December 2025

Brave Bison Group plc

("Brave Bison" or the "Company", together with its subsidiaries "the Group")

Exercise of Options, Issue of Equity and Total Voting Rights

Brave Bison, the next-generation marketing and technology partner for global brands, announces that on 10 December 2025 certain employees of the Group exercised option rights over an aggregate of 202,451 ordinary shares of 2 pence each ("Ordinary Shares" and the "Options").

As a result, application will be made for a total of 202,451 new Ordinary Shares to be admitted to trading on AIM ("Admission"). Admission is expected to occur at 8.00 a.m. on 18 December 2025 and the new Ordinary Shares will, on issue, rank pari passu in all respects with the Company's existing Ordinary Shares.

On Admission, the Company will have a total of 102,474,298 Ordinary Shares in issue. No Ordinary Shares are held in treasury. The figure of 102,474,298 may be used by the Company's shareholders as the denominator in the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

For further information please contact:

Brave Bison Group plc

Oliver Green, Chairman via Cavendish

Theo Green, Chief Growth Officer

Philippa Norridge, Chief Financial Officer

Cavendish Capital Markets Tel: +44 (0) 20 7220 0500

Nominated Adviser & Joint Broker 

Ben Jeynes / Teddy Whiley / Elysia Bough - Corporate Finance

Michael Johnson / Sunila de Silva - ECM

Singer Capital Markets Tel: +44 (0) 20 7496 3000

Joint Broker

Alex Hardwicke

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END